The global continuous renal replacement therapy market revenue was around US$ 1.5 billion in 2021 and is estimated to reach US$ 2.8 billion by 2031, growing at a compound annual growth rate (CAGR) of ...

Clinical trials suggesting that hemodiafiltration offers a survival benefit over hemodialysis have largely been conducted among the prevalent dialysis population, so investigators examined an incident ...

BY SYLVESTER OJENAGBON Chronic kidney disease is a significant public health concern in Nigeria. Studies show its ...

On April 19, 2025, the Blood Purification Professional Committee (BPPC) of the China Medical Device Industry Association (CMDIA) gathered in Liuyang, Hunan, for its annual conference, themed "Synergy ...

According to the agreement between the two bodies, for starters, 20 first-generation learners from lower economic backgrounds will be awarded the scholarship.

The following is a summary of "Importance Of Uric Acid Levels In Geriatric Patients With Respiratory Failure Under ...

CytoSorbents Corporation , a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today announced the appointment of Melanie ...

The number of patients with chronic kidney disease is increasing with aging. According to the Health Insurance Review and Assessment Service, the number of patients with chronic kidney disease surged ...

CytoSorbents Corporation , a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today announced the appointment of Thomas ...

There is currently no strong evidence that additional immune therapy benefits patients with renal cell carcinoma who were ...

The pharmacokinetic profile of brivaracetam is unaltered in patients with impaired renal function or by hemodialysis. It is not necessary to adjust treatment initiation doses or to administer ...